The aim of this study is to investigate the efficacy of bright light therapy in SAD. This is a placebo-controlled, double-blind randomized controlled trial (RCT).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
60
Bright light therapy
In this arm, patients will not get any bright-light therapy in a double-blind setting
Research unit, ODL Terveys Oy, Albertinkatu 18 A
Oulu, Finland
RECRUITINGRemission as defined by the SIGH-SAD
Time frame: 28 (visit window from 26 to 30 days) days after the inclusion day
Decrease of the severity of symptoms as assessed by SIGH-SAD, Hamilton anxiety scale, and Beck depression inventory-21
Time frame: 28 (visit window from 26 to 30 days) days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.